AspenBio Pharma Inc

Entity type image
Type: Company
Name: AspenBio Pharma Inc
First reported May 06 2013 - Updated May 06 2013 - 1 reports

Venaxis, Inc. (APPY) - Financial and Strategic SWOT Analysis Review - new company profile report

Venaxis, Inc. (Venaxis), formerly AspenBio Pharma, Inc., is an emerging in-vitro diagnostic company. The company discovers, develops and manufactures, licenses and distributes novel proprietary products related to human and animal health. It is advancing ... [Published TransWorldNews - May 06 2013]
First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Venaxis, Inc. (APPY) - Financial and Strategic SWOT Analysis Review

SummaryVenaxis, Inc. (Venaxis), formerly AspenBio Pharma, Inc., is an emerging in-vitro diagnostic company. The company discovers, develops and manufactures, licenses and distributes novel proprietary products related to human and animal health. It is ... [Published MarketResearch.com - Apr 22 2013]

More Content

All (14) | News (11) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
Venaxis, Inc. (APPY) - Financial and Strategic ... [Published TransWorldNews - May 06 2013]
Venaxis, Inc. (APPY) - Financial and Strategic ... [Published MarketResearch.com - Apr 22 2013]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Dec 13 2012]
Venaxis, Inc. Announces Full Exercise of Underw... [Published Financial Services - Dec 12 2012]
AspenBio Pharma Changes Company Name to Venaxis... [Published PR Newswire: Health - Dec 12 2012]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Nov 20 2012]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Nov 16 2012]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Nov 13 2012]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Sep 27 2012]
AspenBio to Provide Investors with Clinical and... [Published PR Newswire - Sep 25 2012]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Sep 18 2012]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Sep 10 2012]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Aug 16 2012]
8-K - AspenBio Pharma, Inc. (0001167419) (Filer) [Published SEC Filings - Aug 08 2012]
1
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
Venaxis, Inc. Announces Full Exercise of Underw... [Published Financial Services - Dec 12 2012]
AspenBio Pharma Changes Company Name to Venaxis... [Published PR Newswire: Health - Dec 12 2012]
AspenBio to Provide Investors with Clinical and... [Published PR Newswire - Sep 25 2012]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.